Dsm

All those in the lutein sector in favour of EFSA's claims methodology, say 'eye'...

EFSA speaks on disputed lutein claims: Only “normal vision” eligible

By Shane Starling

The European Food Safety Authority (EFSA) has responded to industry bafflement about why it did not assess submitted eye health claims for the carotenoid, lutein, by saying the submitted claims were not “eligible” – without expanding on why its health...

ONC is strong in omega-3 supplements, but could drug apps hold greater promise?

DSM eyes generic omega-3 drug space with €420m ONC buy

By Shane Starling

DSM will use its global reach to drive its latest acquisition - fish-sourced omega-3 leader, Ocean Nutrition Canada, beyond its core North American market – but sees opportunities in generic drugs that may prove more lucrative.

Provexis keeps Fruitflow powder dry, axes UK R&D facility

Provexis keeps Fruitflow powder dry, axes UK R&D facility

By Ben Bouckley

UK plc Provexis plans to shut its UK research and development (R&D) facility, as the company seeks to reposition itself within the sports nutrition market and co-develop a powder version of heart health ingredient Fruitflow with DSM, which it says...

Martek: End of an era

Martek name to disappear as DSM creates new Nutritional Lipids business

By Elaine Watson

Seven months after sealing a billion dollar deal to acquire Martek, DSM has created Nutritional Lipids, a new division that will combine Martek’s algal omega-3 and omega-6 products and DSM Nutritional Products’ polyunsaturated fatty acid (PUFA) portfolio.

Supply: Beta-carotene club and beyond

Special Edition: Antioxidants

Supply: Beta-carotene club and beyond

By Jane Byrne

In the second part of our antioxidants special, NutraIngredients focuses on the carotenoids where the vitamin A converter, beta-carotene, is still lording it over lutein and lycopene and DSM and BASF’s synthetic versions continue to dominate that particular...

Health claim dossiers cost €5m, says DSM

Health claim dossiers cost €5m, says DSM

By Shane Starling from Amsterdam

DSM’s human nutrition corporate scientist, Wim Saris, spoke with Shane Starling recently after chairing a weight management and satiety conference in Amsterdam. He voiced his concern about spiralling health claim costs muzzling innovation.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All